Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for Hyperphagia in Prader-Willi Syndrome
NCT02629991Phase 2Completed
- Sponsor
- Montefiore Medical Center
- Start
- Oct 2015
- Primary completion
- Dec 2016
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin nasal spray in Prader-Willi syndrome (PWS), hyperphagia, sponsored by Montefiore Medical Center. Started Oct 2015; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
Prader-Willi syndrome (PWS)hyperphagia
Beyond the preview
Go deeper on NCT02629991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02629991.